{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:38:35Z","timestamp":1758397115125,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T00:00:00Z","timestamp":1445817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"European Regional Devolpment Fund","award":["122-09-019"],"award-info":[{"award-number":["122-09-019"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","award":["122-09-017"],"award-info":[{"award-number":["122-09-017"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Excellence Cluster Inflammation@Interfaces","doi-asserted-by":"publisher","award":["DFG EXC306\/1 and 2"],"award-info":[{"award-number":["DFG EXC306\/1 and 2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00403-015-1606-7","type":"journal-article","created":{"date-parts":[[2015,10,26]],"date-time":"2015-10-26T06:27:57Z","timestamp":1445840877000},"page":"31-38","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Immunoadsorber for specific apheresis of autoantibodies in the treatment of bullous pemphigoid"],"prefix":"10.1007","volume":"308","author":[{"given":"Michael","family":"Mersmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Dworschak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Ebermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Komorowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Schlumberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried","family":"St\u00f6cker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Probst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,26]]},"reference":[{"key":"1606_CR1","first-page":"434","volume":"7","author":"F Bertram","year":"2009","unstructured":"Bertram F, Brocker EB, Zillikens D, Schmidt E (2009) Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges 7:434\u2013440","journal-title":"J Dtsch Dermatol Ges"},{"key":"1606_CR2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1523-1747.1999.00546.x","volume":"112","author":"L Borradori","year":"1999","unstructured":"Borradori L, Sonnenberg A (1999) Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 112:411\u2013418","journal-title":"J Invest Dermatol"},{"key":"1606_CR3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2133.2000.03661.x","volume":"143","author":"S Christophoridis","year":"2000","unstructured":"Christophoridis S, Budinger L, Borradori L, Hunziker T, Merk HF, Hertl M (2000) IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis. Br J Dermatol 143:349\u2013355","journal-title":"Br J Dermatol"},{"key":"1606_CR4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","volume":"128","author":"G Zenzo Di","year":"2008","unstructured":"Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M (2008) Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin Immunol 128:415\u2013426","journal-title":"Clin Immunol"},{"key":"1606_CR5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1172\/JCI114812","volume":"86","author":"LA Diaz","year":"1990","unstructured":"Diaz LA, Ratrie H III, Saunders WS, Futamura S, Squiquera HL, Anhalt GJ, Giudice GJ (1990) Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest 86:1088\u20131094","journal-title":"J Clin Invest"},{"key":"1606_CR6","first-page":"577","volume":"42","author":"R Dopp","year":"2000","unstructured":"Dopp R, Schmidt E, Chimanovitch I, Leverkus M, Brocker EB, Zillikens D (2000) IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol 42:577\u2013583","journal-title":"J Am Acad Dermatol"},{"key":"1606_CR7","first-page":"833","volume":"13","author":"R Eming","year":"2015","unstructured":"Eming R, Sticherling M, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Pfeiffer C, Schuster V, Zillikens D, Goebeler M et al (2015) S2\u00a0k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid. J Dtsch Dermatol Ges 13:833\u2013844","journal-title":"J Dtsch Dermatol Ges"},{"key":"1606_CR8","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","volume":"127","author":"JA Fairley","year":"2007","unstructured":"Fairley JA, Burnett CT, Fu CL, Larson DL, Fleming MG, Giudice GJ (2007) A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice. J Invest Dermatol 127:2605\u20132611","journal-title":"J Invest Dermatol"},{"key":"1606_CR9","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.4049\/jimmunol.151.10.5742","volume":"151","author":"GJ Giudice","year":"1993","unstructured":"Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Liu Z, Diaz LA (1993) Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 151:5742\u20135750","journal-title":"J Immunol"},{"key":"1606_CR10","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/eji.200535349","volume":"36","author":"JE Herrero-Gonzalez","year":"2006","unstructured":"Herrero-Gonzalez JE, Brauns O, Egner R, Ronspeck W, Mascaro JM Jr, Jonkman MF, Zillikens D, Sitaru C (2006) Immunoadsorption against two distinct epitopes on human type XVII collagen abolishes dermal-epidermal separation induced in vitro by autoantibodies from pemphigoid gestationis patients. Eur J Immunol 36:1039\u20131048","journal-title":"Eur J Immunol"},{"key":"1606_CR11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1091-6660.1999.t01-2-.x","volume":"3","author":"F Hiepe","year":"1999","unstructured":"Hiepe F, Pfuller B, Wolbart K, Bruns A, Leinenbach HP, Hepper M, Schossler W, Otto V (1999) C1q: a multifunctional ligand for a new immunoadsorption treatment. Ther Apher 3:246\u2013251","journal-title":"Ther Apher"},{"key":"1606_CR12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4049\/jimmunol.1100596","volume":"187","author":"M Hirose","year":"2011","unstructured":"Hirose M, Recke A, Beckmann T, Shimizu A, Ishiko A, Bieber K, Westermann J, Zillikens D, Schmidt E, Ludwig RJ (2011) Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice. J Immunol 187:1176\u20131183","journal-title":"J Immunol"},{"key":"1606_CR13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1747.2002.19529.x","volume":"119","author":"S Hofmann","year":"2002","unstructured":"Hofmann S, Thoma-Uszynski S, Hunziker T, Bernard P, Koebnick C, Stauber A, Schuler G, Borradori L, Hertl M (2002) Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 119:1065\u20131073","journal-title":"J Invest Dermatol"},{"key":"1606_CR14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/jid.2008.305","volume":"129","author":"H Iwata","year":"2009","unstructured":"Iwata H, Kamio N, Aoyama Y, Yamamoto Y, Hirako Y, Owaribe K, Kitajima Y (2009) IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment. J Invest Dermatol 129:919\u2013926","journal-title":"J Invest Dermatol"},{"key":"1606_CR15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archdermatol.2007.9","volume":"144","author":"Y Iwata","year":"2008","unstructured":"Iwata Y, Komura K, Kodera M, Usuda T, Yokoyama Y, Hara T, Muroi E, Ogawa F, Takenaka M, Sato S (2008) Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid. Arch Dermatol 144:41\u201348","journal-title":"Arch Dermatol"},{"key":"1606_CR16","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2012.35","volume":"132","author":"P Joly","year":"2012","unstructured":"Joly P, Baricault S, Sparsa A, Bernard P, Bedane C, Duvert-Lehembre S, Courville P, Bravard P, Remond B, Doffoel-Hantz V, Benichou J (2012) Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol 132:1998\u20132004","journal-title":"J Invest Dermatol"},{"key":"1606_CR17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","volume":"346","author":"P Joly","year":"2002","unstructured":"Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D\u2019Incan M, Plantin P, Bedane C, Young P, Bernard P (2002) A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 346:321\u2013327","journal-title":"N Engl J Med"},{"key":"1606_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0955-3886(90)90099-5","volume":"11","author":"JG Kadar","year":"1990","unstructured":"Kadar JG, Borberg H (1990) Biocompatibility of extracorporeal immunoadsorption systems. Transfus Sci 11:223\u2013239","journal-title":"Transfus Sci"},{"key":"1606_CR19","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jaad.2014.06.014","volume":"71","author":"M Kasperkiewicz","year":"2014","unstructured":"Kasperkiewicz M, Schulze F, Meier M, van Beek N, Nitschke M, Zillikens D, Schmidt E (2014) Treatment of bullous pemphigoid with adjuvant immunoadsorption: a case series. J Am Acad Dermatol 71:1018\u20131020","journal-title":"J Am Acad Dermatol"},{"key":"1606_CR20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/jaut.2000.0437","volume":"15","author":"A Kromminga","year":"2000","unstructured":"Kromminga A, Scheckenbach C, Georgi M, Hagel C, Arndt R, Christophers E, Brocker EB, Zillikens D (2000) Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. J Autoimmun 15:293\u2013300","journal-title":"J Autoimmun"},{"key":"1606_CR21","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1537-2995.2006.00927.x","volume":"46","author":"G Kumlien","year":"2006","unstructured":"Kumlien G, Ullstrom L, Losvall A, Persson LG, Tyden G (2006) Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 46:1568\u20131575","journal-title":"Transfusion"},{"key":"1606_CR22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.136.4.1231","volume":"136","author":"RS Labib","year":"1986","unstructured":"Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA (1986) Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 136:1231\u20131235","journal-title":"J Immunol"},{"key":"1606_CR23","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","volume":"337","author":"SM Langan","year":"2008","unstructured":"Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J (2008) Bullous pemphigoid and pemphigus vulgaris\u2014incidence and mortality in the UK: population based cohort study. BMJ 337:a180","journal-title":"BMJ"},{"key":"1606_CR24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/exd.12355","volume":"23","author":"J Langenhan","year":"2014","unstructured":"Langenhan J, Dworschak J, Saschenbrecker S, Komorowski L, Schlumberger W, Stocker W, Westermann J, Recke A, Zillikens D, Schmidt E, Probst C (2014) Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmogleins. Exp Dermatol 23:253\u2013259","journal-title":"Exp Dermatol"},{"key":"1606_CR25","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1172\/JCI116856","volume":"92","author":"Z Liu","year":"1993","unstructured":"Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, Giudice GJ (1993) A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 92:2480\u20132488","journal-title":"J Clin Invest"},{"key":"1606_CR26","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","volume":"161","author":"G Marazza","year":"2009","unstructured":"Marazza G, Pham HC, Scharer L, Pedrazzetti PP, Hunziker T, Trueb RM, Hohl D, Itin P, Lautenschlager S, Naldi L, Borradori L (2009) Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol 161:861\u2013868","journal-title":"Br J Dermatol"},{"key":"1606_CR27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jim.2009.04.013","volume":"346","author":"KA Messingham","year":"2009","unstructured":"Messingham KA, Noe MH, Chapman MA, Giudice GJ, Fairley JA (2009) A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid. J Immunol Methods 346:18\u201325","journal-title":"J Immunol Methods"},{"key":"1606_CR28","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4049\/jimmunol.1001753","volume":"187","author":"KN Messingham","year":"2011","unstructured":"Messingham KN, Srikantha R, DeGueme AM, Fairley JA (2011) FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid. J Immunol 187:553\u2013560","journal-title":"J Immunol"},{"key":"1606_CR29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1744-9987.2012.01075.x","volume":"16","author":"D Meyersburg","year":"2012","unstructured":"Meyersburg D, Schmidt E, Kasperkiewicz M, Zillikens D (2012) Immunoadsorption in dermatology. Ther Apher Dial 16:311\u2013320","journal-title":"Ther Apher Dial"},{"key":"1606_CR30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nm1496","volume":"13","author":"W Nishie","year":"2007","unstructured":"Nishie W, Sawamura D, Goto M, Ito K, Shibaki A, McMillan JR, Sakai K, Nakamura H, Olasz E, Yancey KB, Akiyama M, Shimizu H (2007) Humanization of autoantigen. Nat Med 13:378\u2013383","journal-title":"Nat Med"},{"key":"1606_CR31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1523-1747.1999.00497.x","volume":"112","author":"J Perriard","year":"1999","unstructured":"Perriard J, Jaunin F, Favre B, Budinger L, Hertl M, Saurat JH, Borradori L (1999) IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180. J Invest Dermatol 112:141\u2013147","journal-title":"J Invest Dermatol"},{"key":"1606_CR32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1526-0968.2003.00017.x","volume":"7","author":"W Ronspeck","year":"2003","unstructured":"Ronspeck W, Brinckmann R, Egner R, Gebauer F, Winkler D, Jekow P, Wallukat G, Muller J, Kunze R (2003) Peptide based adsorbers for therapeutic immunoadsorption. Ther Apher Dial 7:91\u201397","journal-title":"Ther Apher Dial"},{"key":"1606_CR33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","volume":"138","author":"B Rzany","year":"2002","unstructured":"Rzany B, Partscht K, Jung M, Kippes W, Mecking D, Baima B, Prudlo C, Pawelczyk B, Messmer EM, Schuhmann M, Sinkgraven R, Buchner L, Budinger L, Pfeiffer C, Sticherling M, Hertl M, Kaiser HW, Meurer M, Zillikens D, Messer G (2002) Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age. Arch Dermatol 138:903\u2013908","journal-title":"Arch Dermatol"},{"key":"1606_CR34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","volume":"136","author":"E Schmidt","year":"2000","unstructured":"Schmidt E, Obe K, Brocker EB, Zillikens D (2000) Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 136:174\u2013178","journal-title":"Arch Dermatol"},{"key":"1606_CR35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1523-1747.2000.00141.x","volume":"115","author":"E Schmidt","year":"2000","unstructured":"Schmidt E, Reimer S, Kruse N, Jainta S, Brocker EB, Marinkovich MP, Giudice GJ, Zillikens D (2000) Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. J Invest Dermatol 115:842\u2013848","journal-title":"J Invest Dermatol"},{"key":"1606_CR36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00403-009-1024-9","volume":"302","author":"E Schmidt","year":"2010","unstructured":"Schmidt E, Zillikens D (2010) Immunoadsorption in dermatology. Arch Dermatol Res 302:241\u2013253","journal-title":"Arch Dermatol Res"},{"key":"1606_CR37","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt E, Zillikens D (2013) Pemphigoid diseases. Lancet 381:320\u2013332","journal-title":"Lancet"},{"key":"1606_CR38","unstructured":"Schmidt E, Zillikens D (2013) Immunoadsorption for autoimmune bullous disease. In: Braun N (Ed) Fundamentals and applications of immunoadsorption. Uni-Med, Bremen, 2nd edn, pp 46\u201356"},{"key":"1606_CR39","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ajpath.2014.05.007","volume":"184","author":"FS Schulze","year":"2014","unstructured":"Schulze FS, Beckmann T, Nimmerjahn F, Ishiko A, Collin M, Kohl J, Goletz S, Zillikens D, Ludwig R, Schmidt E (2014) Fcgamma receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid. Am J Pathol 184:2185\u20132196","journal-title":"Am J Pathol"},{"key":"1606_CR40","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","volume":"16","author":"C Sitaru","year":"2007","unstructured":"Sitaru C, Dahnrich C, Probst C, Komorowski L, Blocker I, Schmidt E, Schlumberger W, Rose C, Stocker W, Zillikens D (2007) Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol 16:770\u2013777","journal-title":"Exp Dermatol"},{"key":"1606_CR41","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1523-1747.2002.01720.x","volume":"118","author":"C Sitaru","year":"2002","unstructured":"Sitaru C, Schmidt E, Petermann S, Munteanu LS, Brocker EB, Zillikens D (2002) Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. J Invest Dermatol 118:664\u2013671","journal-title":"J Invest Dermatol"},{"key":"1606_CR42","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0092-8674(81)90115-X","volume":"24","author":"JR Stanley","year":"1981","unstructured":"Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, Katz SI (1981) Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 24:897\u2013903","journal-title":"Cell"},{"key":"1606_CR43","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.4049\/jimmunol.0903101","volume":"184","author":"H Ujiie","year":"2010","unstructured":"Ujiie H, Shibaki A, Nishie W, Sawamura D, Wang G, Tateishi Y, Li Q, Moriuchi R, Qiao H, Nakamura H, Akiyama M, Shimizu H (2010) A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen. J Immunol 184:2166\u20132174","journal-title":"J Immunol"},{"key":"1606_CR44","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1056\/NEJM200211283472220","volume":"347","author":"G Wallukat","year":"2002","unstructured":"Wallukat G, Muller J, Hetzer R (2002) Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy. N Engl J Med 347:1806","journal-title":"N Engl J Med"},{"key":"1606_CR45","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.jid.5700681","volume":"127","author":"JJ Zone","year":"2007","unstructured":"Zone JJ, Taylor T, Hull C, Schmidt L, Meyer L (2007) IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice. J Invest Dermatol 127:1167\u20131174","journal-title":"J Invest Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-015-1606-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-015-1606-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-015-1606-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T16:28:28Z","timestamp":1692116908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-015-1606-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,26]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["1606"],"URL":"https:\/\/doi.org\/10.1007\/s00403-015-1606-7","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"type":"print","value":"0340-3696"},{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2015,10,26]]}}}